Nuvelo(NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo(NUVO)

NUVO 0.170

+169,917.0%

Aug 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (118)	12/11/2006 3:50:47 PM
From: DewDiligence_on_SI	of 140

I'm not sure what NUVO thought they saw [with rNAPc2] that could resurrect it. When your lead drug is on shaky ground—as Alf has been since the FDA demanded tough “outcomes” endpoints for phase-3 (ask AMGN)—it makes sense to fill up the pipeline with whatever you can get. I’m inclined to agree that rNAPc2 is worth less than $2/share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next